If hair loss becomes a concern, speak to your doctor
Dipeptidyl peptidase-4 (DPP-4) inhibitors like linagliptin, sitagliptin (dose-adjusted), and saxagliptin provide modest A1c reduction (0.50.8%) without hypoglycemia or weight gain
In clinical trials, retatrutide has been administered as a once-weekly subcutaneous injection, consistent with other agents in its class (Jastreboff et al., NEJM , 2023)
Overall take-home: most peptides are a scam Whats my general fact-check and review of BPC-157
HS AMG, der von der KK im Ausnahmefall der Erstattung abzglich 5 % an die Apotheke ausgezahlt wird
Smaller Biotechs and Collaborators: Companies like Zealand Pharma, Glycadia, and others have GLP-1 analogs or co-agonists in early trials, often in partnership with larger pharma (e.g., Novo Nordisk collaboration with Zealand)